Ads
    Related conference
  1. Effects on Metabolic Parameters of Addition of SGLT‐2 Inhibitors on Patients with Type2 Diabetes Inadequately Controlled with DPP‐IV Inhibitors and Metformin
  2. Role of SGLT-2 Inhibitors in Treatment of Patients with Type 2 Diabetes and NAFLD
  3. Diabetes and its Complications and SGLT-2 Inhibitors: A Novel Therapy for Type 2 Diabetes Mellitus
  4. Addition of Metformin to Liraglutide, A GLP-1 Receptor Agonist, Improves Glycemic Control in Patients with Type 2 Diabetes Mellitus
  5. SGLT-2 inhibitors: the glucosuric antidiabetics
  6. Comparative study: Efficacy and tolerability of vildagliptin vs. pioglitazone as an add-on therapy to metformin in poorly controlled type 2 diabetes mellitus patients in Punjab
  7. Improvement in lipid profile of the patients with saxagliptin as add on therapy to metformin in patients of type 2 DM who were previously on metformin alone with uncontrolled diabetes
  8. Antidepressant Activity of SGLT – 2 Inhibitors in Albinomice, an Experimental Study
  9. Evaluate the Efficacy of Metformin and Glimepiride with Metformin in Patients with Type II Diabetes Mellitus
  10. FREQUENCY OF ASPIRIN RESISTANCE IN PATIENTS WITH TYPE 1 AND 2 DIABETES MELLITUS AND ITS ASSOCIATION WITH METABOLIC PARAMETERS